Press release content from Globe Newswire. The AP news staff was not involved in its creation. Beyond Celiac Announces a Research Grant Program with Janssen to Support Critical Research into ... Beyond CeliacFebruary 16, 2021 GMT Salvatore (Salvo) Alesci, MD, PhD, Chief Scientist and Strategy Officer and Ken Kilgore, PhD, MBA, Chief Scientific Investment Officer Salvatore (Salvo) Alesci, MD, PhD, Chief Scientist and Strategy Officer and Ken Kilgore, PhD, MBA, Chief Scientific Investment Officer Philadelphia, PA, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, today announced a two-year joint research grant program with Janssen Research & Development, LLC (Janssen) through its World Without Disease Accelerator group. Through a commitment of up to $1 million in funds and services, Beyond Celiac together with Janssen will co-fund research focusing on risk detection, prevention, interception and cure of celiac disease. Emphasis will be placed on gaining an increased understanding of areas such as the gut microbiome, induction of immune tolerance and biomarkers of risk and progression.